D-penicillamine

Jerusalem, Israel, September 8, 2026 Scinai Immunotherapeutics has announced a strategic refocusing of its research and development portfolio following...

Chicago, Illinois, USA, September 8, 2026 Orphalan has initiated the global Phase 3 TRADITiONAL clinical trial evaluating an investigational...